19 September 2025 | 6:01AM BST | NOVOb.CO | 12m Price Target: Dkr392.00 | Price: Dkr392.50 | Downside: 0.1% | | --- | --- | --- | --- | | NVO | 12m Price Target: $61.00 | Price:$61.85 | Downside: 1.4% | In the week to date of EASD, Novo shares have risen by c.13% vs. SXDP c.-1% which, on the one hand, is generous in our view, as while management seemed incrementally more positive on the pipeline and obesity portfolio at the R&D event, the data presented by Novo at the conference were largely incremental, i ...